Yes, an ideal economy would incorporate the most productive aspects of each economic system, and I recognise that the social democracies are far more ideal than corporate capitalism and that this why you are so drawn to them.
I just don't see how any of the enterprises in social democracies could favourably compare with Mondragón and the many advantages it offers to its members; an economy built on the foundation of co-operatives would undoubtedly outcompete an economy built on the Nordic model.
The apparent innovation in the pharmaceutical industry is a myth; studies have been conducted showing that all the drugs that were approved by the FDA, were publicly funded.
Sources:
Even if Congress prohibits rebates and requires drug companies to pass along every dime in savings to customers, which almost every CEO in attendance pledged to do, tens of millions of patients will still be hitting their out-of-pocket maximums.
www.modernhealthcare.com
This report shows that NIH funding contributed to published research associated with every one of the 210 new drugs approved by the Food and Drug Administration from 2010–2016. Collectively, this research involved >200,000 years of grant funding totaling more than $100 billion. The analysis...
www.pnas.org
Objective To determine the extent to which late stage development of new drugs relies on support from public funding. Design Cohort study. Setting All new drugs containing one or more new molecular entities approved by the US Food and Drug Administration (FDA) between January 2008 and December...
www.bmj.com
The United States Federal Government provides at least 44% of the funding of corporate research in the pharmaceutical industry.
The pharmaceutical industry claims that it's a misconception that the Government is largely responsible for the "innovation" in the pharmaceutical industry, and they cite the 75% figure for the number of patents that the private pharmaceutical sector patents on a yearly basis...
..The problem of course is that 85-90% of the new drugs provide no clinical advantages over existing drugs. There really is no need for the pharmaceutical industry to exist as a private sector.
You articulated yourself very well; I enjoy reading your posts.